Skip to content

External validation of a risk stratification predicting hypothyroidism after hemithyroidectomy (INFORM-2-trial)

External validation of a risk stratification predicting hypothyroidism after hemithyroidectomy (INFORM-2-trial) - INFORM-2-trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57697
Enrollment
500
Registered
2017-07-21
Start date
2017-10-02
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidims low thyroid hormone levels

Interventions

None listed

Sponsors

Maasstadziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Planned hemithyroidectomy 2. Age 18 years or older

Exclusion criteria

Exclusion criteria: 1. Thyroid dysfunction preoperatively ((sub-)clinical hypo- or hyperthyroidism) 2. Previous thyroid surgery 3. History of external beam irradiation on the neck 4. Pregnancy 5. Unable to give informed consent 6. Completion thyreoidectomy

Design outcomes

Primary

MeasureTime frame
The primary study endpoint is the correlation between the actual risk for thyroxine supplementation and the predicted risk of thyroxine supplementation, according to the risk stratification of Lee et al.

Secondary

MeasureTime frame
Secondary study endpoints consist of the incidence of hypothyroidism and risk factors for hypothyroidism.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)